Review maps CBD's diverse molecular targets including serotonin, TRPV1, and cannabinoid receptors
CBD acts on a remarkably diverse set of molecular targets, with the serotonin 5-HT1A receptor and TRPV1 channel emerging as primary targets alongside effects on cannabinoid and opioid receptors.
Quick Facts
What This Study Found
CBD's effects are mediated through multiple molecular mechanisms rather than a single target. Primary targets include the serotonin 5-HT1A receptor and TRPV1 channel. Additional targets include cannabinoid receptors (CB1, CB2), opioid receptors, and other GPCRs and ion channels. This multi-target profile explains CBD's broad spectrum of effects.
Key Numbers
Two primary targets identified: serotonin 5-HT1A receptor and TRPV1 channel. Additional targets include CB1, CB2, opioid receptors, GPR55, and other GPCRs and ion channels.
How They Did This
Review synthesizing in vitro and in vivo evidence, randomized clinical trial data, and real-world observations on CBD's molecular targets and signaling pathways.
Why This Research Matters
Understanding CBD's diverse targets explains why it shows effects across anxiety, pain, inflammation, and epilepsy, and helps guide development of more targeted therapeutics.
The Bigger Picture
CBD's polypharmacology (acting on many targets) is both its therapeutic advantage and its scientific challenge. Understanding which targets matter for which conditions could enable more precise cannabinoid-based medicines.
What This Study Doesn't Tell Us
Many target interactions characterized in vitro at concentrations that may not be achieved clinically; the relative contribution of each target to therapeutic effects remains unclear.
Questions This Raises
- ?Which of CBD's many targets are most relevant for its anti-anxiety vs. anti-seizure vs. anti-inflammatory effects?
- ?Can drugs be designed to selectively hit CBD's most therapeutic targets?
Trust & Context
- Key Stat:
- Two primary targets: serotonin 5-HT1A receptor and TRPV1 channel
- Evidence Grade:
- Comprehensive review of molecular pharmacology evidence, though clinical relevance of some targets is uncertain.
- Study Age:
- Published in 2020.
- Original Title:
- Diversity of molecular targets and signaling pathways for CBD.
- Published In:
- Pharmacology research & perspectives, 8(6), e00682 (2020)
- Authors:
- de Almeida, Douglas L, Devi, Lakshmi A
- Database ID:
- RTHC-02497
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How does CBD work differently from THC?
While THC primarily activates CB1 receptors to produce psychoactive effects, CBD acts on a wider range of targets including serotonin receptors, TRPV1 channels, and GPR55, without producing intoxication. This multi-target profile explains why CBD affects such a broad range of conditions.
Why does CBD seem to help so many different conditions?
CBD's ability to modulate multiple receptor systems, including serotonin (relevant to anxiety/mood), TRPV1 (pain), and various ion channels (seizures), means it can influence diverse physiological processes. However, not all claimed benefits have been rigorously proven in clinical trials.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-02497APA
de Almeida, Douglas L; Devi, Lakshmi A. (2020). Diversity of molecular targets and signaling pathways for CBD.. Pharmacology research & perspectives, 8(6), e00682. https://doi.org/10.1002/prp2.682
MLA
de Almeida, Douglas L, et al. "Diversity of molecular targets and signaling pathways for CBD.." Pharmacology research & perspectives, 2020. https://doi.org/10.1002/prp2.682
RethinkTHC
RethinkTHC Research Database. "Diversity of molecular targets and signaling pathways for CB..." RTHC-02497. Retrieved from https://rethinkthc.com/research/de-2020-diversity-of-molecular-targets
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.